Dr. Reddy's Laboratories
174 hedge funds and large institutions have $1.41B invested in Dr. Reddy's Laboratories in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 58 reducing their positions, and 15 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
10% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 58
9% more capital invested
Capital invested by funds: $1.3B → $1.41B (+$111M)
4% more funds holding
Funds holding: 168 → 174 (+6)
3.37% less ownership
Funds ownership: 75.89% → 72.52% (-3.4%)
Top Buyers
Top Sellers
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$34.8M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$32M |
| 3 |
JP Morgan Chase
New York
|
-$20.5M |
| 4 |
Morgan Stanley
New York
|
-$19.3M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
-$12.9M |
RDY Hedge Fund Activity: Q1 2015 in Review
174 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2015, worth a combined $1.41B — up 8.5% from $1.3B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new RDY positions and 15 closed out — a net gain of 8 holders — while 64 added to existing stakes and 58 trimmed.
The largest buyer was Fisher Asset Management, adding an estimated $56.4M. The largest seller was Fidelity International, cutting an estimated $34.8M.
- 174 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2015, up from 168 in Q4 2014.
- Funds reported $1.41B of Dr. Reddy's Laboratories stock for Q1 2015, up 8.5% quarter-over-quarter.
- 23 funds opened new Dr. Reddy's Laboratories positions in Q1 2015 and 15 closed out, a net change of +8 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2015 was Fisher Asset Management, an estimated $56.4M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2015 was Fidelity International, an estimated $34.8M sold.
Based on aggregated 13F filings for Q1 2015.